{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:18:24Z","timestamp":1783131504220,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["212734-2019"],"award-info":[{"award-number":["212734-2019"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2023010"],"award-info":[{"award-number":["2023010"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jprot.2026.105660","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:13:19Z","timestamp":1776787999000},"page":"105660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treatment-na\u00efve PDAC"],"prefix":"10.1016","volume":"328","author":[{"given":"Manoj","family":"Amrutkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Vefferstad","family":"Finstadsveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut J\u00f8rgen","family":"Labori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar P.","family":"Gladhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10485","key":"10.1016\/j.jprot.2026.105660_bb0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jprot.2026.105660_bb0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13304-021-01186-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"74","author":"Gugenheim","year":"2022","journal-title":"Updates Surg."},{"issue":"5","key":"10.1016\/j.jprot.2026.105660_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jprot.2026.105660_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2020.00245","article-title":"Neoadjuvant treatment in pancreatic cancer","volume":"10","author":"Oba","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jprot.2026.105660_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","article-title":"Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials","volume":"160","author":"van Dam","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.jprot.2026.105660_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cancers9110157","article-title":"Pancreatic cancer chemoresistance to gemcitabine","volume":"9","author":"Amrutkar","year":"2017","journal-title":"Cancers (Basel)."},{"issue":"9","key":"10.1016\/j.jprot.2026.105660_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jprot.2026.105660_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1287459","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Hartupee","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jprot.2026.105660_bb0055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.jprot.2026.105660_bb0060","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1111\/cas.15890","article-title":"Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: current understanding and future directions","volume":"114","author":"Sato","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-018-0927-5","article-title":"Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis","volume":"18","author":"Thomas","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jprot.2026.105660_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216859","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: challenges and opportunities","volume":"591","author":"Qin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jprot.2026.105660_bb0075","article-title":"Pancreatic cancer and fibrosis: targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jprot.2026.105660_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","article-title":"Emerging mechanisms and promising approaches in pancreatic cancer metabolism","volume":"15","author":"Wu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.jprot.2026.105660_bb0085","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1245\/s10434-011-2086-4","article-title":"Significance of pathologic response to preoperative therapy in pancreatic cancer","volume":"18","author":"Chun","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"18","key":"10.1016\/j.jprot.2026.105660_bb0090","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1158\/1078-0432.CCR-18-1359","article-title":"Fibrotic response to neoadjuvant therapy predicts survival in pancreatic cancer and is measurable with collagen-targeted molecular MRI","volume":"26","author":"Erstad","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0095","first-page":"337","article-title":"Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma","volume":"38","author":"Miyashita","year":"2018","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.jprot.2026.105660_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/bjc.2013.415","article-title":"Stromal disrupting effects of nab-paclitaxel in pancreatic cancer","volume":"109","author":"Alvarez","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.jprot.2026.105660_bb0105","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-20-3892","article-title":"Induction of ADAM10 by radiation therapy drives fibrosis, resistance, and epithelial-to-Mesenchyal transition in pancreatic cancer","volume":"81","author":"Mueller","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.jprot.2026.105660_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222155","article-title":"Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer","volume":"14","author":"Matsuda","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jprot.2026.105660_bb0115","article-title":"Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma","volume":"21","author":"Hartley","year":"2020","journal-title":"Pract. Lab. Med."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40364-025-00805-y","article-title":"Proteomics in pancreatic cancer","volume":"13","author":"Cai","year":"2025","journal-title":"Biomark Res."},{"key":"10.1016\/j.jprot.2026.105660_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.104973","article-title":"Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines","volume":"288","author":"Lau","year":"2023","journal-title":"J. Proteomics"},{"issue":"7","key":"10.1016\/j.jprot.2026.105660_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100575","article-title":"Functional and clinical proteomic exploration of pancreatic cancer","volume":"22","author":"Huang","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jprot.2026.105660_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/proteomes11030024","article-title":"Proteomics-driven biomarkers in pancreatic cancer","volume":"11","author":"Ramalhete","year":"2023","journal-title":"Proteomes"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7150\/ijms.36337","article-title":"Biological and proteomic characteristics of an immortalized human pancreatic stellate cell line","volume":"17","author":"Sun","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/1878-0261.13344","article-title":"Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma","volume":"17","author":"Amrutkar","year":"2023","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.jprot.2026.105660_bb0150","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ijc.34867","article-title":"Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass","volume":"154","author":"Stillger","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.jprot.2026.105660_bb0155","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"2","key":"10.1016\/j.jprot.2026.105660_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1878-0261.13759","article-title":"Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer","volume":"19","author":"Amrutkar","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jprot.2026.105660_bb0165","series-title":"Washington Protocol for the Examination of Specimens From Patients With Carcinoma of the Pancreas","author":"Lawrence","year":"2020"},{"issue":"2","key":"10.1016\/j.jprot.2026.105660_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0016-5085(98)70209-4","article-title":"Identification, culture, and characterization of pancreatic stellate cells in rats and humans","volume":"115","author":"Bachem","year":"1998","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010023","article-title":"Commonly used pancreatic stellate cell cultures differ phenotypically and in their interactions with pancreatic cancer cells","volume":"8","author":"Lenggenhager","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jprot.2026.105660_bb0180","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","article-title":"Protein aggregation capture on microparticles enables multipurpose proteomics sample preparation","volume":"18","author":"Batth","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0185","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","article-title":"Dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts","volume":"13","author":"Demichev","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jprot.2026.105660_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2024.110239","article-title":"Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer\u2019s disease biomarkers","volume":"411","author":"Gorska","year":"2024","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12935-023-03138-8","article-title":"Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0200","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jprot.2026.105660_bb0205","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"4","key":"10.1016\/j.jprot.2026.105660_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040601","article-title":"Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer","volume":"13","author":"Amrutkar","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrg2673","article-title":"RNA processing and its regulation: global insights into biological networks","volume":"11","author":"Licatalosi","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jprot.2026.105660_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597608","article-title":"Intracellular transport in cancer metabolic reprogramming","volume":"8","author":"Sneeggen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jprot.2026.105660_bb0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0235","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s41598-023-28635-8","article-title":"RNA disruption is a widespread phenomenon associated with stress-induced cell death in tumour cells","volume":"13","author":"Butler","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jprot.2026.105660_bb0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12885-016-2197-1","article-title":"RNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell lines","volume":"16","author":"Narendrula","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jprot.2026.105660_bb0245","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10555-021-10004-4","article-title":"Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets","volume":"40","author":"Andersen","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.jprot.2026.105660_bb0250","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.trecan.2025.04.012","article-title":"The plasticity of cancer-associated fibroblasts","volume":"11","author":"Xia","year":"2025","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10555-023-10164-5","article-title":"Deciphering cellular plasticity in pancreatic cancer for effective treatments","volume":"43","author":"Uddin","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"11","key":"10.1016\/j.jprot.2026.105660_bb0260","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/s41588-024-01890-9","article-title":"Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment","volume":"56","author":"Shiau","year":"2024","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jprot.2026.105660_bb0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jprot.2026.105660_bb0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1158\/1541-7786.MCR-15-0348","article-title":"Chemotherapy-induced inflammatory gene signature and protumorigenic phenotype in pancreatic CAFs via stress-associated MAPK","volume":"14","author":"Toste","year":"2016","journal-title":"Mol. Cancer Res."}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391926000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391926000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:32:45Z","timestamp":1783128765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391926000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S1874391926000631"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2026.105660","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treatment-na\u00efve PDAC","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2026.105660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105660"}}